Inavil With 43% Of January Japan Influenza Market, Tamiflu’s Lead Very Thin
This article was originally published in PharmAsia News
Executive Summary
The single inhalation anti-influenza drug Inavil has shown strong growth in early 2013, attaining 43% of the prescription-based influenza market in January.